|
|
Article: Cappella Inc. Secures $17.3 Million Series C Investment.
- Article from:
- PR Newswire
- Article date:
- June 15, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
- New and existing investors complete a $17.3 million Series C investment
- Experienced medical device executive, Dr. Art Rosenthal, appointed as CEO
- Aggressive launch of Sideguard(TM) Sidebranch stent in EU following recent CE Marking
- Expansion of management team, R&D and manufacturing capacity in Galway, Ireland
WILMINGTON, Del. and GALWAY, Ireland, June 15 /PRNewswire/ -- Cappella, Inc. (Cappella) announces today that it has completed a $17.3 million Series C investment, led by new investors, Fountain Healthcare Partners and Mitsui & Co. Venture Partners (MCVP). Enterprise Ireland also participated in this round alongside ...